Iradimed (IRMD) Net Cash Flow (2013 - 2026)

Iradimed (IRMD) has 14 years of Net Cash Flow data on file, last reported at $5.2 million in Q1 2026.

• On a quarterly basis, Net Cash Flow rose 374.04% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $6.0 million, a 16.13% increase from a year earlier, with the FY2025 full-year figure at -$1.1 million, down 143.5% from the prior year.
• Net Cash Flow for Q1 2026 stood at $5.2 million, up from -$5.4 million in the prior quarter.
• Over the last five years, Net Cash Flow for IRMD reached as high as $5.2 million in Q1 2026 and fell as low as -$15.2 million in Q1 2023.
• Historically, Net Cash Flow has averaged -$330961.9 across 5 years, with a median of $2.4 million in 2022.
• Across the five-year window, Net Cash Flow plunged 1676.35% in 2022 and surged 374.04% in 2026, its largest moves.
• Year by year, Net Cash Flow stood at $2.4 million in 2022, then increased by 27.37% to $3.0 million in 2023, then plunged by 83.03% to $512147.0 in 2024, then plunged by 1147.99% to -$5.4 million in 2025, then jumped by 197.16% to $5.2 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $5.2 million in Q1 2026, -$5.4 million in Q4 2025, and $3.5 million in Q3 2025.